China Feihe Limited (HK:6186)
:6186
Want to see HK:6186 full AI Analyst Report?
Top Page
China Feihe Limited
(6186)
Select Model
Select Model
Rating:62Neutral
Price Target:
HK$3.50
▼(-13.15% Downside)
Action:Reiterated
Date:05/02/26
The score is driven primarily by resilient financial positioning (low leverage) but offset by weaker 2025 operating and cash flow performance. Technical signals are soft and below key moving averages, while valuation is supported by a high dividend yield but tempered by recent margin and cash conversion pressure.
Positive Factors
Balance sheet strength
Very low leverage and sizable equity provide financial resilience: the conservative capital structure supports investment flexibility, helps absorb demand shocks or supply disruptions, and preserves optionality for channel expansion or strategic spending over the next several quarters.
Negative Factors
Revenue decline
A double-digit revenue drop indicates weakening demand, pricing or mix issues. Sustained top-line contraction undermines scale economies, increases unit fixed-cost exposure, and can force margin trade-offs that impair long-term profitability and reinvestment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Very low leverage and sizable equity provide financial resilience: the conservative capital structure supports investment flexibility, helps absorb demand shocks or supply disruptions, and preserves optionality for channel expansion or strategic spending over the next several quarters.
Read all positive factors
China Feihe Limited (6186) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$29.25B
Dividend Yield6.7%
Average Volume (3M)26.36M
Price to Earnings (P/E)17.4
Beta (1Y)0.62
Revenue Growth-12.70%
EPS Growth-45.69%
CountryHK
Employees9,590
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.21
Shares Outstanding9,067,252,000
10 Day Avg. Volume24,266,952
30 Day Avg. Volume26,356,611
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)1.38
Price to Sales (P/S)1.86
P/FCF Ratio52.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$4.51Price Target Upside11.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.27
Revenue Forecast (FY)HK$18.72B
China Feihe Limited Business Overview & Revenue Model
Company Description
China Feihe Limited, an investment holding company, produces and sells infant milk formula products in Mainland China and the United States. The company offers a range of raw milk, adult milk powders, liquid milk products and health care products,...
How the Company Makes Money
China Feihe primarily makes money by selling branded dairy nutrition products, with infant formula as its main revenue driver. Revenue is generated from (1) sales of infant formula across multiple product tiers and price points, where pricing and ...
China Feihe Limited Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
88
Very Positive
Cash Flow
46
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.11B | 20.75B | 19.53B | 21.31B | 22.78B |
| Gross Profit | 11.78B | 13.76B | 12.66B | 13.95B | 16.01B |
| EBITDA | 3.30B | 6.24B | 5.51B | 6.25B | 8.41B |
| Net Income | 1.94B | 3.57B | 3.39B | 4.94B | 6.87B |
Balance Sheet | |||||
| Total Assets | 34.05B | 35.73B | 36.19B | 35.52B | 31.48B |
| Cash, Cash Equivalents and Short-Term Investments | 16.30B | 19.00B | 19.15B | 19.11B | 17.18B |
| Total Debt | 855.59M | 1.08B | 1.64B | 1.50B | 1.11B |
| Total Liabilities | 7.92B | 8.32B | 9.86B | 10.04B | 9.08B |
| Stockholders Equity | 24.44B | 25.93B | 24.94B | 23.99B | 20.92B |
Cash Flow | |||||
| Free Cash Flow | 643.12M | 2.68B | 2.61B | 3.80B | 4.80B |
| Operating Cash Flow | 2.21B | 4.18B | 4.15B | 6.28B | 6.81B |
| Investing Cash Flow | 9.56M | -1.32B | 386.70M | -4.80B | -2.44B |
| Financing Cash Flow | -3.47B | -3.03B | -2.71B | -1.98B | -4.25B |
China Feihe Limited Technical Analysis
Negative
4.03
Price Trends
3.55
Negative
3.76
Negative
3.99
Negative
Market Momentum
-0.07
Positive
35.54
Neutral
18.53
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6186, the sentiment is Negative. The current price of 4.03 is above the 20-day moving average (MA) of 3.41, above the 50-day MA of 3.55, and above the 200-day MA of 3.99, indicating a bearish trend. The MACD of -0.07 indicates Positive momentum. The RSI at 35.54 is Neutral, neither overbought nor oversold. The STOCH value of 18.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6186.
China Feihe Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$119.19B | 9.13 | 14.19% | 6.66% | 7.95% | -2.88% | |
67 Neutral | HK$48.39B | 16.62 | 18.74% | 3.26% | 2.03% | 1.43% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$29.25B | 17.37 | 7.69% | 6.70% | -12.70% | -45.69% | |
62 Neutral | HK$68.21B | ― | 24.09% | 5.46% | -1.95% | 20.50% | |
59 Neutral | HK$67.47B | 33.90 | 3.79% | 3.62% | -7.24% | 1390.75% | |
48 Neutral | HK$2.44B | 9.61 | 2.84% | 2.90% | 1.14% | -25.47% |
* Consumer Defensive Sector Average
HK:6186
China Feihe Limited
3.23
-2.48
-43.43%
HK:0151
Want Want China Holdings
4.10
-0.87
-17.57%
HK:0288
WH Group
9.29
3.14
51.18%
HK:2319
China Mengniu Dairy Co
17.43
-0.13
-0.76%
HK:0322
Tingyi (Cayman Islands) Holding
12.10
-0.50
-3.97%
HK:1717
Ausnutria Dairy Corp. Ltd.
1.37
-0.49
-26.34%
China Feihe Limited Corporate Events
China Feihe Sets 2026 AGM to Approve Dividend, Board Changes and Share Mandates
Apr 28, 2026
China Feihe has called its annual general meeting for 5 June 2026 in Beijing, where shareholders will review and adopt the audited consolidated financial statements for the year ended 31 December 2025 and vote on a proposed final dividend of HK$0....
China Feihe Profit Slumps as Revenue Declines, Dividend Trimmed
Mar 26, 2026
China Feihe Limited reported a challenging 2025 financial year, with revenue falling 12.7% to RMB18.11 billion and gross profit declining 14.5% to RMB11.78 billion. Profit for the year dropped 42.7% to RMB2.09 billion, reflecting weaker operating ...
China Feihe Declares Final Cash Dividend for 2025 Financial Year
Mar 26, 2026
China Feihe Limited has proposed a final ordinary cash dividend of HKD 0.129 per share for the financial year ended 31 December 2025, with the payout subject to shareholder approval at a meeting scheduled for 5 June 2026. The ex-dividend date is s...
China Feihe Sets March 2026 Board Meeting to Approve 2025 Results and Dividend Recommendation
Mar 16, 2026
China Feihe Limited has scheduled a board meeting for 26 March 2026 to review and approve the group’s audited financial results for the year ended 31 December 2025. The board will also consider recommending a final dividend and address other...
China Feihe Channels RMB200 Million of Idle Cash Into SPD Bank Product
Mar 2, 2026
China Feihe has subscribed, via its wholly owned subsidiary Feihe HLJ, to a RMB200 million non-principal-guaranteed financial product offered by SPD Bank, using idle funds to seek a 2.5% expected annual return until December 7, 2026. This latest i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.